(CMRE) Costamare - Overview
Stock: Containerships, Dry Bulk Vessels, Charter Services
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 4.02% |
| Yield on Cost 5y | 5.79% |
| Yield CAGR 5y | 6.21% |
| Payout Consistency | 89.6% |
| Payout Ratio | 19.9% |
| Risk 5d forecast | |
|---|---|
| Volatility | 35.8% |
| Relative Tail Risk | -1.92% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.14 |
| Alpha | 30.10 |
| Character TTM | |
|---|---|
| Beta | 0.896 |
| Beta Downside | 1.056 |
| Drawdowns 3y | |
|---|---|
| Max DD | 57.81% |
| CAGR/Max DD | 0.37 |
Description: CMRE Costamare January 15, 2026
Costamare Inc. (NYSE: CMRE) is a Monaco-based marine transportation company that owns and operates a mixed fleet of containerships and dry-bulk vessels. Its vessels are primarily chartered on long-term, fixed-rate contracts to liner operators for container cargoes and to various bulk customers for dry-bulk shipments, providing relatively stable cash flows across the cyclical shipping market.
As of 12 February 2025 the fleet comprised 68 containerships (totaling roughly 1.3 million TEU capacity) and 38 dry-bulk vessels (about 1.0 million dwt). The average age of the container fleet is ~7 years, positioning Costamare well within the industry’s “young-fleet” premium that can command higher charter rates. In Q4 2024 the company reported an adjusted EBITDA margin of 22 % and a net debt-to-EBITDA ratio of 2.1×, reflecting a balance between leverage and earnings resilience.
Key drivers for Costamare’s performance include global container trade volumes, which are projected to grow 3-4 % annually through 2028, and the ongoing shortage of new-build container ships that supports higher time-charter rates. Additionally, stricter IMO 2023 emissions regulations are prompting charterers to favor newer, fuel-efficient vessels-an advantage for Costamare’s relatively modern fleet. For a deeper dive into Costamare’s valuation metrics and scenario analysis, the ValueRay platform offers a concise, data-rich overview.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 321.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA -0.71 > 1.0 |
| NWC/Revenue: 18.82% < 20% (prev 26.32%; Δ -7.50% < -1%) |
| CFO/TA 0.07 > 3% & CFO 264.9m > Net Income 321.7m |
| Net Debt (1.06b) to EBITDA (538.2m): 1.96 < 3 |
| Current Ratio: 1.68 > 1.5 & < 3 |
| Outstanding Shares: last quarter (120.3m) vs 12m ago 0.66% < -2% |
| Gross Margin: 39.79% > 18% (prev 0.29%; Δ 3950 % > 0.5%) |
| Asset Turnover: 31.43% > 50% (prev 33.04%; Δ -1.62% > 0%) |
| Interest Coverage Ratio: 3.08 > 6 (EBITDA TTM 538.2m / Interest Expense TTM 100.4m) |
Altman Z'' 2.08
| A: 0.07 (Total Current Assets 663.8m - Total Current Liabilities 394.6m) / Total Assets 3.86b |
| B: 0.21 (Retained Earnings 810.0m / Total Assets 3.86b) |
| C: 0.07 (EBIT TTM 309.3m / Avg Total Assets 4.55b) |
| D: 0.46 (Book Value of Equity 815.0m / Total Liabilities 1.76b) |
| Altman-Z'' Score: 2.08 = BBB |
Beneish M -3.62
| DSRI: 0.34 (Receivables 26.6m/94.2m, Revenue 1.43b/1.73b) |
| GMI: 0.73 (GM 39.79% / 29.22%) |
| AQI: 1.51 (AQ_t 0.11 / AQ_t-1 0.08) |
| SGI: 0.83 (Revenue 1.43b / 1.73b) |
| TATA: 0.01 (NI 321.7m - CFO 264.9m) / TA 3.86b) |
| Beneish M-Score: -3.62 (Cap -4..+1) = AAA |
What is the price of CMRE shares?
Over the past week, the price has changed by -5.13%, over one month by +1.58%, over three months by +18.81% and over the past year by +54.52%.
Is CMRE a buy, sell or hold?
- StrongBuy: 0
- Buy: 0
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the CMRE price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 12.5 | -21.5% |
| Analysts Target Price | 12.5 | -21.5% |
| ValueRay Target Price | 18.7 | 17.1% |
CMRE Fundamental Data Overview February 03, 2026
P/S = 1.0008
P/B = 1.0082
P/EG = -0.8
Revenue TTM = 1.43b USD
EBIT TTM = 309.3m USD
EBITDA TTM = 538.2m USD
Long Term Debt = 1.31b USD (from longTermDebt, last quarter)
Short Term Debt = 272.1m USD (from shortTermDebt, last quarter)
Debt = 1.58b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.06b USD (from netDebt column, last quarter)
Enterprise Value = 3.14b USD (2.09b + Debt 1.58b - CCE 525.3m)
Interest Coverage Ratio = 3.08 (Ebit TTM 309.3m / Interest Expense TTM 100.4m)
EV/FCF = 15.71x (Enterprise Value 3.14b / FCF TTM 200.1m)
FCF Yield = 6.36% (FCF TTM 200.1m / Enterprise Value 3.14b)
FCF Margin = 13.99% (FCF TTM 200.1m / Revenue TTM 1.43b)
Net Margin = 22.49% (Net Income TTM 321.7m / Revenue TTM 1.43b)
Gross Margin = 39.79% ((Revenue TTM 1.43b - Cost of Revenue TTM 861.4m) / Revenue TTM)
Gross Margin QoQ = 71.96% (prev 55.33%)
Tobins Q-Ratio = 0.81 (Enterprise Value 3.14b / Total Assets 3.86b)
Interest Expense / Debt = 1.13% (Interest Expense 17.9m / Debt 1.58b)
Taxrate = 21.0% (US default 21%)
NOPAT = 244.4m (EBIT 309.3m * (1 - 21.00%))
Current Ratio = 1.68 (Total Current Assets 663.8m / Total Current Liabilities 394.6m)
Debt / Equity = 0.78 (Debt 1.58b / totalStockholderEquity, last quarter 2.03b)
Debt / EBITDA = 1.96 (Net Debt 1.06b / EBITDA 538.2m)
Debt / FCF = 5.28 (Net Debt 1.06b / FCF TTM 200.1m)
Total Stockholder Equity = 2.27b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.07% (Net Income 321.7m / Total Assets 3.86b)
RoE = 14.18% (Net Income TTM 321.7m / Total Stockholder Equity 2.27b)
RoCE = 8.64% (EBIT 309.3m / Capital Employed (Equity 2.27b + L.T.Debt 1.31b))
RoIC = 6.00% (NOPAT 244.4m / Invested Capital 4.07b)
WACC = 5.63% (E(2.09b)/V(3.67b) * Re(9.22%) + D(1.58b)/V(3.67b) * Rd(1.13%) * (1-Tc(0.21)))
Discount Rate = 9.22% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.94%
[DCF Debug] Terminal Value 80.82% ; FCFF base≈243.7m ; Y1≈160.0m ; Y5≈73.0m
Fair Price DCF = 10.54 (EV 2.33b - Net Debt 1.06b = Equity 1.27b / Shares 120.4m; r=5.90% [WACC]; 5y FCF grow -40.0% → 2.90% )
[DCF Warning] FCF declining rapidly (-40.0%), DCF may be unreliable
EPS Correlation: -36.61 | EPS CAGR: -49.90% | SUE: -4.0 | # QB: 0
Revenue Correlation: 17.65 | Revenue CAGR: -6.00% | SUE: 0.17 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.72 | Chg30d=+0.020 | Revisions Net=+1 | Analysts=1
EPS next Year (2026-12-31): EPS=2.90 | Chg30d=+0.000 | Revisions Net=+1 | Growth EPS=-3.3% | Growth Revenue=-16.9%